Back to Dividend Stocks
Pfizer Inc. (PFE) logo

Pfizer Inc.

S&P 500
PFE|Healthcare|Drug Manufacturers - General|$25.68|P/E 19.6|MCap 146.4B|NYSE

Last update: May 9, 2026 at 09:32

Dividend Safety Rating

54/ 100Caution

PFE's dividend shows some areas that warrant monitoring. Strengths include a 71.6 debt-to-equity & 31.6% operating margin. Areas of concern: 131.3% earnings payout ratio & 107.7% fcf payout ratio.

Based on 15 of 15 metrics

Strengths

  • Operating Margin: 31.6%Healthy operating margin provides a wide buffer.
  • Gross Margin: 75.4%High gross margin signals strong pricing power.
  • Dividend Streak: 11+ yrsLong, uninterrupted dividend track record.

Risks

  • Earnings Payout Ratio: 131.3%High earnings payout ratio leaves little safety margin.
  • FCF Payout Ratio: 107.7%Free cash flow is tight relative to the dividend.
  • CFO Payout Ratio: 151.9%Operating cash flow leaves little room for the payout.

Payout & Coverage

Warning
Earnings Payout Ratio
131.3%Danger
FCF Payout Ratio
107.7%Danger
CFO Payout Ratio
151.9%Danger
Interest Coverage
3.8xCaution

Balance Sheet

Caution
Net Debt / Total Assets
30.2%Caution
Current Ratio
1.2xCaution
Debt-to-Equity
71.6Safe

Profitability

Safe
Return on Equity
8.3%Caution
Operating Margin
31.6%Very Safe
Gross Margin
75.4%Very Safe
Profit Margin Stability
VolatileWarning

Dividend Track Record

Safe
Dividend Streak
11+ yrsVery Safe
Dividend Cut
NoneVery Safe
5-Year Dividend CAGR
3.6%Caution
Earnings Stability
StableSafe

About Pfizer Inc.

Pfizer Inc. is a research-based global biopharmaceutical company founded in 1849 and headquartered in New York. It focuses on the discovery, development, manufacture, marketing, sales, and distribution of biopharmaceutical products worldwide, targeting developed and emerging markets to advance wellness, prevention, treatments, and cures for the most feared diseases. Operating in the health technology sector, specifically pharmaceuticals: major, Pfizer Inc. addresses critical areas such as oncology, rare diseases, internal medicine, inflammation and immunology, vaccines, anti-infectives, gene therapy, medicinal sciences, and precision medicine. Notable advancements include acquisitions like Global Blood Therapeutics in 2023 to bolster its biopharmaceutical portfolio, alongside recent clinical trial successes in prostate cancer, lung cancer, and bladder cancer therapies. With approximately 81,000 employees, Pfizer Inc. generates substantial revenue, reported at $63.63 billion for the fiscal year, and maintains a significant presence in the global market through innovative pipelines and partnerships.

Dividend Overview

Dividend Yield

6.70%

Annual Dividend

$1.72

Frequency

Quarterly

Payout Ratio

131.30%

FCF Payout Ratio

107.67%

Stock Price

$25.68

52-Week Range

$21.97 $28.75

Dividend History (2016–2025)

PFE annual dividend per share and yield history

Earnings & Profitability

PFE earnings per share and net profit margin

Key Dates

Last Ex-Dividend Date

May 8, 2026

Next Payment Date

June 12, 2026

Dividend Growth

3-Year Dividend CAGR

2.44%

5-Year Dividend CAGR

3.59%

10-Year Dividend CAGR

4.93%

3-Year Total Growth

7.50%

5-Year Total Growth

19.27%

10-Year Total Growth

61.87%

Income Calculator

PFE Dividend Calculator

Total Investment

$2,568.00

Annual Income

$172.00

Quarterly Income

$43.00

Monthly Income

$14.33

Similar Dividend Stocks

StockYield5Y CAGRPrice
Pfizer Inc. (PFE) logo
PFE
6.70%3.59%$25.68
Amgen Inc. (AMGN) logo
AMGN
2.95%8.27%$331.70
Bristol-Myers Squibb Company (BMY) logo
BMY
4.45%-9.52%$56.16
Boston Scientific Corporation (BSX) logo
BSX
0.00%N/A$53.93
Danaher Corporation (DHR) logo
DHR
0.79%14.93%$171.16
Gilead Sciences Inc. (GILD) logo
GILD
2.43%3.04%$131.33
Merck & Co., Inc. (MRK) logo
MRK
2.98%6.75%$111.38
Stryker Corporation (SYK) logo
SYK
1.21%7.62%$285.47

Frequently Asked Questions

What is PFE's current dividend yield?
Pfizer Inc. (PFE) currently has a dividend yield of 6.70%, based on a stock price of $25.68 and an annual dividend of $1.72.
When is PFE's next dividend payment date?
PFE's next ex-dividend date is 2026-05-08 and the next payment date is 2026-06-12. You must own the stock before the ex-dividend date to receive the upcoming payment.
How much does PFE pay in dividends per year?
Pfizer Inc. paid $1.72 per share in annual dividends in 2025. The dividends are paid quarterly.
Has PFE been increasing its dividend?
Pfizer Inc. has grown its dividend at a 5-year CAGR of 3.59% and a 10-year CAGR of 4.93%.
Is PFE's dividend safe?
Pfizer Inc. has a payout ratio of 131.30%. Its free cash flow payout ratio is 107.67%. The payout ratio is above 100%, which may indicate the company is paying more in dividends than it earns. This could be unsustainable long-term.
How is PFE's Dividend Safety Rating calculated?
The Dividend Safety Rating evaluates Pfizer Inc.'s dividend sustainability across four categories: Payout & Coverage (30%), Balance Sheet (20%), Profitability (20%), and Dividend Track Record (30%). Each metric is rated from "Very Safe" to "Danger" based on industry-standard thresholds, with sector-specific adjustments for healthcare companies. The overall score ranges from 0 to 100.

Want to understand how we rate dividend safety? Read our full methodology

Track PFE Dividends with OnlyDividends

What will PFE actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.

This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.

Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Safety Rating, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.

Market data provided by Twelve Data.